Terry Rosen, Ph.D.

Terry Rosen, Ph.D.

Chair of the BoardatArcus Biosciences· In proxies 2022–2025

Pay in FY2023+12% from the year before

Terry Rosen, Ph.D. was paid $10.1M in FY2023 (Dec), up 12%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Arcus Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. IDEAYA BiosciencesPublic company · 3 yr
    • Chair of the Board2023 – Present · 3 yrNo stock prices for these years
  2. Arcus BiosciencesPublic company · 4 yr
    • Chief Executive Officer and Director2022 – Present · 4 yrNo stock prices for these years
  3. Arcus Biosciences, Inc.Public company · 11 yr
    • Director2015 – Present · 11 yrNo stock prices for these years
  4. Epiodyne, Inc.Public company
    • Director? – PresentNo stock prices for these years
  5. Simcha Therapeutics Holding Company, LLCPublic company
    • Director? – PresentNo stock prices for these years
  6. Sonoma Biotherapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  7. PACT Pharma, Inc.Public company · 6 yr
    • Director2016 – 2022 · 6 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?